Sean Collins Archive — Page 1 of 2

Cropped grayscale view of a shirtless young man holding his lower back, with a red glow highlighting the painful area.
December 6, 2023

Study connects patients who visit the ED with acute flare-ups of chronic back pain with remote integrative health coaching program

Vanderbilt will pilot an eight-session remote integrative health coaching program for patients who visit the emergency department with acute flare-ups of chronic low back pain.

From left, Sean Collins, MD, MSc, Wesley Self, MD, MPH, Jessica Collins, program director, Vanderbilt Coordinating Center, and Matt Shotwell, PhD, play key roles in a now-international clinical trial platform that is investigating therapies aimed at reducing complications in patients hospitalized with COVID-19.
January 5, 2023

VUMC-led COVID-19 clinical trial platform goes international

The ACTIV-4 Host Tissue clinical trial platform, which is designed to investigate therapies targeting the host tissue response to COVID-19 to mitigate lung injury, is now being expanded internationally.

Glowing cyan electrocardiogram waveform with two prominent heartbeat spikes against a dark blue grid background.
September 16, 2021

VUMC team to test personalized acute heart failure treatment

Researchers at Vanderbilt have been awarded a five-year, $4 million federal grant to test whether a personalized medicine strategy will improve outcomes for patients hospitalized with acute heart failure.

VUMC NEWS logo in white lettering inside a cyan and yellow outlined square on a blue gradient background.
July 26, 2021

VUMC, NIH launch clinical trial to test novel therapies to protect host tissue against COVID-19

Vanderbilt University Medical Center researchers, supported by the National Institutes of Health (NIH), are leading a nationwide clinical trial to explore the safety and effectiveness of a group of novel drugs designed to protect patients hospitalized with COVID-19 at high risk of poor outcomes.

VUMC NEWS logo in white lettering inside a cyan and yellow outlined square on a blue gradient background.
May 26, 2021

VUMC researchers receive grant from the National Heart, Lung, and Blood Institute to develop biomarkers to improve the diagnosis of acute heart failure

Researchers at Vanderbilt University Medical Center (VUMC) have received a four-year, $6.2-million grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health to develop a novel panel of biomarkers to improve the diagnosis of acute heart failure (AHF).

Three-dimensional illustration of a coronavirus particle with a textured gray spherical surface, red spike proteins, and smaller yellow surface structures; blurred particles appear in the background.
May 6, 2021

VUMC to lead national study to treat severe COVID complications

The Vanderbilt Institute for Clinical and Translational Research (VICTR) has been awarded a major federal grant to lead a national trial of treatments targeting the Renin Angiotensin Aldosterone System (RAAS) in patients hospitalized with COVID-19.